2-Fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 95.0%, 10g

MASLINIC ACID, 95%, 100mg

1-Azabicyclo[2.2.2]octane-4-carboxylic acid, 95%, 1g

3-amino-N-(4-bromophenyl)propanamide hydrochloride, 95.0%, 1g

bScope BS.1152-EPLPH for phase contrast. Biocular with HWF 10x/20 mm eyepieces and Quadruple revolver E-plan Phase 10/20/S40 S100x

5-Bromo-2-(methylthio)pyrimidine-carboxylic acid, 97.0%, 1g

2,3-Dichlorophenylacetic acid, 98.0%, 100g

N-((1R,2R)-2-Aminocyclohexyl)-4-methylbenzenesulfonamide, 97.0%, 250mg

3-Bromofuro[3,4-b]pyridine-5,7-dione, 95.0%, 250mg

4,5-Diiodo-benzene-1,2-diamine, 97%, 1g

5-Oxo-pyrrolidine-3-carboxylic acid, 95.0%, 25g

Benzyltriethylammonium Chloride>98.0%(HPLC)(T)25g

5-Bromo-3-fluoro-4-methylbenzaldehyde, 95.0%, 10g